To determine whether treatment with the diabetes medication, Januvia (sitagliptin), with or without another diabetes medicine, Actos (pioglitazone), will improve insulin secretion and insulin response individuals with Impaired Glucose Tolerance (IGT), a form of prediabetes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
3
Sitagliptin 100 mg tablet daily + Pioglitazone PLACEBO 15 mg capsule daily
Sitagliptin 100 mg tablet daily + Pioglitazone 15 mg capsule daily
Sitagliptin placebo 100 mg tablet daily + Pioglitazone placebo 15 mg capsule daily
Grady Memorial Hospital
Atlanta, Georgia, United States
Emory University Hospital
Atlanta, Georgia, United States
Insulin Secretion
Not measured as study was prematurely terminated due to unanticipated delays.
Time frame: baseline, 6 months, 9 months (after a 3 month washout)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.